BRC News

A team of researchers at UCL and UCLH have identified the key brain regions that are essential for logical thinking and problem solving.

The BRC-supported research project will monitor infections such as Covid-19, flu and norovirus.

The collaboration between UCLH and Roche Pharmaceuticals aimed to identify barriers for which practical and actionable solutions could be found.

The ASPro-PD study is testing whether treatment with a drug called ambroxol is associated with an improvement in motor and non-motor function compared with placebo.

UCLH has recruited its first patient in a national study looking at whether continuous glucose monitoring can improve pregnancy outcomes for women with early-onset type 2 diabetes.

The UK national screening programme begins from 1 April 2025.

A technique to improve the precision of prostate cancer surgery means that almost twice as many men preserve their erectile function compared to those undergoing standard surgery.

The parts of the brain that are needed to remember words, and how these are affected by a common form of epilepsy, have been identified by a team of neurologists and neurosurgeons at UCL.

A number of BRC-supported researchers have been appointed or re-appointed as National Institute for Health and Care Research Senior Investigators in the NIHR’s 2025 round of awards.

The event highlighted the crucial role of CRPs in the NHS and how NHS employers can develop their CRP workforce.

A large-scale study from UCLH and UCL highlights the real-world impact of life after stroke, revealing the significant burden faced by survivors.

Researchers have found a way to predict when children with arthritis may have painful flare-ups in their joints.

UCLH’s Celebrating Research Open Day on 3 July 2025 will be an interactive event showcasing innovation, clinical trials, and cutting-edge healthcare advancements.

Prof Paola Giunti helped deliver the first-ever treatment for the rare neurodegenerative disease Friedrich’s ataxia.

Researchers have developed a groundbreaking, minimally invasive treatment that could offer hope for millions of people with a form of high blood pressure caused by a commonly overlooked condition.